FindTrial
Sign In

Clinical results and side-effects observation of esophageal squamous cell carcinomas treated with preoperative concurrent chemoradiotherapy based on cisplatin associated with tegafur gimeracil oteracil potassium capsule

Clinical results and side-effects observation of esophageal squamous cell carcinomas treated with preoperative concurrent chemoradiotherapy based on cisplatin associated with tegafur gimeracil oteracil potassium capsule

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-13004449
Enrollment
Unknown
Registered
2013-07-09
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell carcinomas

Interventions

preoperative CCRT group:cisplatin and S1

Sponsors

Department of Radiation Oncology, Xijing Hospital, the Fourth Military Medical University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Local advanced esophageal squamous cell carcinoma; 2. Middle-lower section of sternum; 3. Aged<70 years old; PS<2; KPS=70; 4. T4a or T4b be certified by endoscopic ultrasonography; 5. Patients without severe cardiac and pulmonary disease and other malignancy, had no anti-cancer therapy history.

Exclusion criteria

Exclusion criteria: 1. patients with severe cardiac and pulmonary disease and other malignancy; 2. any T and N stage, with M1; 3. patients had history of anti-cancer therapy before.

Design outcomes

Primary

MeasureTime frame
Tumor regression;—

Contacts

Public ContactXue Ying

Department of Radiation Oncology, Xijing Hospital, the Fourth Military Medical University.

x.ying@yeah.net+86 13709193163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026